-
1.发明申请
公开(公告)号：WO2007140385A2
公开(公告)日：2007-12-06
申请号：PCT/US2007069921
申请日：2007-05-30
Applicant: ABBOTT LAB , DART MICHAEL J , CARROLL WILLIAM A , FLORJANCIC ALAN S , FROST JENNIFER M , GALLAGHER MEGAN E , LI TONGMEI , NELSON DEREK W , PATEL MEENA V , PEDDI SRIDHAR , PEREZ-MEDRANO ARTURO , RYTHER KEITH B , TIETJE KARIN ROSEMARIE , KOLASA TEODOZYJ
Inventor： DART MICHAEL J , CARROLL WILLIAM A , FLORJANCIC ALAN S , FROST JENNIFER M , GALLAGHER MEGAN E , LI TONGMEI , NELSON DEREK W , PATEL MEENA V , PEDDI SRIDHAR , PEREZ-MEDRANO ARTURO , RYTHER KEITH B , TIETJE KARIN ROSEMARIE , KOLASA TEODOZYJ
CPC classification number: C07D277/82 , C07D277/46 , C07D277/48 , C07D277/60 , C07D417/06 , C07D417/12 , C07D477/14 , C07D513/04
Abstract: The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2 , R3 , R4 , and L1 are defined in the specfication, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a and (Rx)n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
Abstract translation: 本发明涉及式（I）化合物或其药物盐，前体药物，前体药物或其组合的盐，其中R1，R2，R3，R4和L1在具体实施方案中定义，包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。 本发明还涉及式（II）化合物或其药物盐，前药，前体药物或其组合的盐，其中R 1a，R 2a和（R x）n如说明书中所定义，包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。
-
公开(公告)号：WO2007140439A3
公开(公告)日：2008-01-24
申请号：PCT/US2007070029
申请日：2007-05-31
Applicant: ABBOTT LAB , DART MICHAEL J , CARROLL WILLIAM A , FLORJANCIC ALAN S , FROST JENNIFER M , GALLAGHER MEGAN E , KOLASA TEODOZYJ , LI TONGMEI , NELSON DEREK W , PATEL MEENA V , PEDDI SRIDHAR , PEREZ-MEDRANO ARTURO , RYTHER KEITH B , TIETJE KARIN ROSEMARIE
Inventor： DART MICHAEL J , CARROLL WILLIAM A , FLORJANCIC ALAN S , FROST JENNIFER M , GALLAGHER MEGAN E , KOLASA TEODOZYJ , LI TONGMEI , NELSON DEREK W , PATEL MEENA V , PEDDI SRIDHAR , PEREZ-MEDRANO ARTURO , RYTHER KEITH B , TIETJE KARIN ROSEMARIE
IPC: C07D277/46 , A61K31/426 , A61K31/427 , A61K31/428 , A61P29/00 , C07D277/48 , C07D277/82 , C07D417/04 , C07D417/06 , C07D417/12 , C07D493/08
CPC classification number: C07D277/46 , A61K31/429 , C07D277/48 , C07D277/82 , C07D417/04 , C07D417/06 , C07D417/12 , C07D493/08 , C07D513/04
Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R 1 , R 2 , R 3 , R 4 , and L 2 , are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
Abstract translation: 本发明涉及式（I）化合物或其药学上可接受的盐，前体药物，前药盐或其组合，其中R 1，R 2，R 2， 在本说明书中定义了含有这些化合物的组合物，以及使用这些化合物治疗病症和障碍的方法，其中，R 3，R 4， 和组合物。
-
3.发明申请N-HYDROXYFORMAMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES 审中-公开作为基质金属蛋白酶抑制剂的N-羟基甲酰胺衍生物
公开(公告)号：WO9906361A3
公开(公告)日：1999-04-22
申请号：PCT/US9815486
申请日：1998-07-27
Applicant: ABBOTT LAB
Inventor： CURTIN MICHAEL L , DAVIDSEN STEVEN K , DELLARIA JOSEPH F JR , FLORJANCIC ALAN S , GIESLER JAMIE , GONG JIANCHUN , GUO YAN , HEYMAN H ROBIN , HOLMS JAMES H , MICHAELIDES MICHAEL R , STEINMAN DOUGLAS H , WADA CAROL K , XU LIANHONG
IPC: C07D233/74 , A61K31/275 , A61K31/351 , A61K31/352 , A61K31/4035 , A61K31/4166 , A61K31/4178 , A61K31/421 , A61K31/428 , A61K31/4439 , A61K31/4465 , A61K31/45 , A61K31/454 , A61K31/50 , A61P1/02 , A61P1/04 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C259/06 , C07C311/05 , C07C311/18 , C07C317/28 , C07C317/40 , C07C323/47 , C07C323/62 , C07D207/40 , C07D207/404 , C07D207/416 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/04 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , A61K31/16 , A61K31/415
CPC classification number: C07D207/404 , C07C311/05 , C07C311/18 , C07C317/28 , C07C323/47 , C07C323/62 , C07D207/408 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12
Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
Abstract translation: 具有式（I）的化合物是基质金属蛋白酶抑制剂。 还公开了抑制哺乳动物基质金属蛋白酶的基质金属蛋白酶抑制组合物和抑制基质金属蛋白酶的方法。
-
公开(公告)号：EP2222165A4
公开(公告)日：2011-01-05
申请号：EP08852528
申请日：2008-11-20
Applicant: ABBOTT LAB
Inventor： FLORJANCIC ALAN S , DART MICHAEL J , RYTHER KEITH B , PEREZ-MEDRANO ARTURO , CARROLL WILLIAM A , PATEL MEENA V , TIETJE KARIN ROSEMARIE , LI TONGMEI , KOLASA TEODOZYJ , GALLAGHER MEGAN E , PEDDI SRIDHAR , FROST JENNIFER M , NELSON DEREK W
IPC: C07D277/46
CPC classification number: C07D417/12 , C07D277/46 , C07D417/06 , C07D513/04 , C07D513/20
-
公开(公告)号：CA2706586A1
公开(公告)日：2009-05-28
申请号：CA2706586
申请日：2008-11-20
Applicant: ABBOTT LAB
Inventor： FLORJANCIC ALAN S , DART MICHAEL J , RYTHER KEITH B , PEREZ-MEDRANO ARTURO , CARROLL WILLIAM A , PATEL MEENA V , TIETJE KARIN ROSEMARIE , LI TONGMEI , KOLASA TEODOZYJ , GALLAGHER MEGAN E , PEDDI SRIDHAR , FROST JENNIFER M , NELSON DEREK W
IPC: C07D277/46 , A61K31/425 , A61P25/04 , A61P29/00 , C07D277/48 , C07D277/60 , C07D417/06 , C07D495/04 , C07D513/04
Abstract: The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, formula (I). wherein R1, R2, R3, R4, and L1 are defined in the specfication, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, formula (II). wherein R1a, R2a, Rx, and n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
-
Patent Agency Ranking
公开(公告)号：CR10473A
公开(公告)日：2009-01-12
申请号：CR10473
申请日：2008-11-28
Applicant: ABBOTT LAB
Inventor： DART MICHAEL J , CARROL WILLIAM A , FLORJANCIC ALAN S , FROST JENNIFER M , GALLAGHER MEGAN E , LI TONGMEI , NELSON DEREK W , PATEL MEENA V , PEDDI SRIDHAR , PEREZ-MEDRANO ARTURO , RYTHER KEITH B , TIETJE KARIN ROSEMARIE , KOLASA TEODOZYJ
IPC: A61K31/426 , A61K31/427 , A61K31/428 , A61K31/429 , A61P29/00 , C07D277/46 , C07D277/48 , C07D277/60 , C07D277/82 , C07D417/06 , C07D417/12 , C07D417/14 , C07D513/04
Abstract: Compuestos de la formula (I), o sales farmaceuticas, prodrogas, sales de prodrogas, o combinaciones de los mismos, donde R1, R2, R3, R4 y L1 se definen en la memoria descriptiva, composiciones que comprenden dichos compuestos, y metodos para tratar condiciones y trastornos usando dichos compuestos y composiciones. La presente invencion tambien se refiere a compuestos de formula (II) o sales farmaceuticas, prodrogas, sales de prodrogas, o combinaciones de los mismos, donde R1a, R2a y Rxn tienen los valores definidos en la memoria descriptiva, composiciones que comprenden dichos compuestos, y metodos para tratar condiciones y trastornos usando dichos compuestos y composiciones.
-
公开(公告)号：NO20085385L
公开(公告)日：2008-12-29
申请号：NO20085385
申请日：2008-12-29
Applicant: ABBOTT LAB
Inventor： RYTHER KEITH B , KOLASA TEODOZYJ , PATEL MEENA V , DART MICHAEL J , CARROLL WILLIAM A , FLORJANCIC ALAN S , FROST JENNIFER M , GALLAGHER MEGAN E , LI TONGMEI , NELSON DEREK W , PEDDI SRIDHAR , PEREZ-MEDRANO ARTURO , TIETJE KARIN ROSEMARIE
IPC: C07D277/28
Abstract: The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L1 are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a and (Rx)n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
-
公开(公告)号：MXPA06012595A
公开(公告)日：2007-05-09
申请号：MXPA06012595
申请日：2005-04-28
Applicant: ABBOTT LAB
Inventor： HIRST GAVIN C , LI TONGMEI , CARROLL WILLIAM A , PEREZ-MEDRANO ARTURO , FLORJANCIC ALAN S , NELSON DEREK W , PEDDI SRIDHAR , BUNNELLE ERIC M , LI BIQIN
IPC: C07D257/06 , A61K31/00 , A61K31/41 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D487/04 , C07D491/04 , C07D491/18
Abstract: Se describe un compuesto que tiene la Formula (I) o Formula (II) como un antagonista de P2X7, en donde A, B, C, Y, Y, Z, m, v, R1, R2, R3, R4 y R5, son como se definen en la descripcion. Se describen metodos y composiciones para tratar enfermedad o condicion modulada por P2X7.
-
公开(公告)号：CA2565211A1
公开(公告)日：2005-11-24
申请号：CA2565211
申请日：2005-04-28
Applicant: ABBOTT LAB
Inventor： HIRST GAVIN C , LI BIQIN , FLORJANCIC ALAN S , PEREZ-MEDRANO ARTURO , CARROLL WILLIAM A , BUNNELLE ERIC M , PEDDI SRIDHAR , NELSON DEREK W
IPC: C07D257/06 , A61K31/41 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D487/04 , C07D491/04 , C07D491/18
Abstract: A compound having Formula (I) or Formula (II) is disclosed as an P2X7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R1, R2, R3, R4, and R5, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X7 are also disclosed.
-
公开(公告)号：ES2189207T3
公开(公告)日：2003-07-01
申请号：ES98936014
申请日：1998-07-27
Applicant: ABBOTT LAB
Inventor： CURTIN MICHAEL L , DAVIDSEN STEVEN K , DELLARIA JOSEPH F JR , FLORJANCIC ALAN S , GIESLER JAMIE , GONG JIANCHUN
IPC: C07D233/74 , A61K31/275 , A61K31/351 , A61K31/352 , A61K31/4035 , A61K31/4166 , A61K31/4178 , A61K31/421 , A61K31/428 , A61K31/4439 , A61K31/4465 , A61K31/45 , A61K31/454 , A61K31/50 , A61P1/02 , A61P1/04 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C259/06 , C07C311/05 , C07C311/18 , C07C317/28 , C07C317/40 , C07C323/47 , C07C323/62 , C07D207/40 , C07D207/404 , C07D207/416 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/04 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07C259/00
Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
-
-
-
-
-
-
-
-
-
Search Results
52
records
(took 0.024 seconds)
